Lunsumio Velo
- Product NDC
- 50242-177
- 11-digit product format
- 502420177
- Labeler code
- 50242
- Product ID
- 50242-177_9f54a0a1-d24b-429e-9a1b-393ed834f1a6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Mosunetuzumab
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Labeler
- Genentech, Inc.
- Application
- BLA761263
- Marketing category
- BLA
- Marketing start
- 2025-12-19
- Substance
- MOSUNETUZUMAB
- Active strength
- 5 mg/.5mL
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Lunsumio Velo
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| MOSUNETUZUMAB | 5 mg/.5mL |
Harmonized Identifiers#
| Field | Values |
|---|---|
| Unii | LDJ89SS0YG |
| Rxcui | 2729433, 2729436, 2729439, 2729442 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 48747306-602a-42cc-957b-5b0c69158eee | Product name | 1 | 20180604 |
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
| db5ebcdb-b6ae-21cd-4dc5-76cd84b5578b | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50242-177-01 | Lunsumio Velo | 1 in 1 CARTON | INJECTION | 1 | 3 | |
| 50242-177-01 | Lunsumio Velo | 0.5 mL in 1 VIAL, GLASS | INJECTION | 0.5 | 3 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50242-177-01 | ML - Milliliter | 50242-177 | 91c44e25-b163-4af0-94e2-76c5479d1dcb | 1 | 2026-02-05 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2729436 | Lunsumio Velo 45 MG in 1 ML Injection | PSN | 6a2b6dc2-48bd-4da7-a611-bc6bae2893c8 | 3 |
| 2729442 | Lunsumio Velo 5 MG in 0.5 ML Injection | PSN | 6a2b6dc2-48bd-4da7-a611-bc6bae2893c8 | 3 |
| 2729433 | mosunetuzumab-axgb 45 MG in 1 ML Injection | PSN | 6a2b6dc2-48bd-4da7-a611-bc6bae2893c8 | 3 |
| 2729439 | mosunetuzumab-axgb 5 MG in 0.5 ML Injection | PSN | 6a2b6dc2-48bd-4da7-a611-bc6bae2893c8 | 3 |
| 2729442 | 0.5 ML mosunetuzumab-axgb 10 MG/ML Injection [Lunsumio] | SBD | 6a2b6dc2-48bd-4da7-a611-bc6bae2893c8 | 3 |
| 2729436 | 1 ML mosunetuzumab-axgb 45 MG/ML Injection [Lunsumio] | SBD | 6a2b6dc2-48bd-4da7-a611-bc6bae2893c8 | 3 |
| 2729439 | 0.5 ML mosunetuzumab-axgb 10 MG/ML Injection | SCD | 6a2b6dc2-48bd-4da7-a611-bc6bae2893c8 | 3 |
| 2729433 | 1 ML mosunetuzumab-axgb 45 MG/ML Injection | SCD | 6a2b6dc2-48bd-4da7-a611-bc6bae2893c8 | 3 |
| 2729442 | Lunsumio 10 MG/ML per 0.5 ML Injection | SY | 6a2b6dc2-48bd-4da7-a611-bc6bae2893c8 | 3 |
| 2729436 | Lunsumio 45 MG per 1 ML Injection | SY | 6a2b6dc2-48bd-4da7-a611-bc6bae2893c8 | 3 |
| 2729436 | Lunsumio 45 MG/ML per 1 ML Injection | SY | 6a2b6dc2-48bd-4da7-a611-bc6bae2893c8 | 3 |
| 2729442 | Lunsumio 5 MG per 0.5 ML Injection | SY | 6a2b6dc2-48bd-4da7-a611-bc6bae2893c8 | 3 |
| 2729439 | mosunetuzumab-axgb 10 MG/ML per 0.5 ML Injection | SY | 6a2b6dc2-48bd-4da7-a611-bc6bae2893c8 | 3 |
| 2729433 | mosunetuzumab-axgb 45 MG per 1 ML Injection | SY | 6a2b6dc2-48bd-4da7-a611-bc6bae2893c8 | 3 |
| 2729433 | mosunetuzumab-axgb 45 MG/ML per 1 ML Injection | SY | 6a2b6dc2-48bd-4da7-a611-bc6bae2893c8 | 3 |
| 2729439 | mosunetuzumab-axgb 5 MG per 0.5 ML Injection | SY | 6a2b6dc2-48bd-4da7-a611-bc6bae2893c8 | 3 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 50242-177-01 | 50242017701 | 1 VIAL, GLASS in 1 CARTON (50242-177-01) / .5 mL in 1 VIAL, GLASS | 2025-12-19 | No | No | Historical |